Atrys Health Future Growth
Future criteria checks 4/6
Atrys Health is forecast to grow earnings and revenue by 87.4% and 6.7% per annum respectively. EPS is expected to grow by 112.9% per annum. Return on equity is forecast to be 4.4% in 3 years.
Key information
87.4%
Earnings growth rate
112.9%
EPS growth rate
| Healthcare earnings growth | 18.3% |
| Revenue growth rate | 6.7% |
| Future return on equity | 4.4% |
| Analyst coverage | Low |
| Last updated | 13 May 2024 |
Recent future growth updates
Recent updates
Atrys Health, S.A.'s (BME:ATRY) 38% Share Price Surge Not Quite Adding Up
May 25
Is Atrys Health, S.A. (BME:ATRY) Trading At A 44% Discount?
Sep 09The Returns At Atrys Health (BME:ATRY) Aren't Growing
Jun 27Returns On Capital Are Showing Encouraging Signs At Atrys Health (BME:ATRY)
Nov 26Atrys Health (BME:ATRY) Might Have The Makings Of A Multi-Bagger
Aug 12Did You Miss Atrys Health's (BME:ATRY) Whopping 387% Share Price Gain?
Feb 02
Atrys Health, S.A. (BME:ATRY) Shares Could Be 33% Above Their Intrinsic Value Estimate
Dec 11Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 252 | 11 | 29 | 42 | 2 |
| 12/31/2025 | 237 | 4 | 25 | 35 | 2 |
| 12/31/2024 | 220 | -3 | 24 | 32 | 3 |
| 12/31/2023 | 206 | -30 | -14 | -1 | N/A |
| 6/30/2023 | 222 | -34 | -28 | -10 | N/A |
| 3/31/2023 | 207 | -28 | -29 | -13 | N/A |
| 12/31/2022 | 163 | -26 | -31 | -15 | N/A |
| 9/30/2022 | 181 | -23 | -25 | -15 | N/A |
| 6/30/2022 | 171 | -22 | -19 | -15 | N/A |
| 3/31/2022 | 148 | -23 | -12 | -5 | N/A |
| 12/31/2021 | 124 | -23 | -4 | 5 | N/A |
| 9/30/2021 | 96 | -16 | -4 | 5 | N/A |
| 6/30/2021 | 67 | -8 | -3 | 6 | N/A |
| 3/31/2021 | 51 | -7 | -5 | 2 | N/A |
| 12/31/2020 | 34 | -6 | -7 | -1 | N/A |
| 9/30/2020 | 26 | -2 | -6 | 0 | N/A |
| 6/30/2020 | 19 | -1 | -5 | 2 | N/A |
| 3/31/2020 | 18 | -1 | -4 | 1 | N/A |
| 12/31/2019 | 17 | 0 | -4 | 1 | N/A |
| 9/30/2019 | 14 | 0 | -3 | 1 | N/A |
| 6/30/2019 | 12 | 0 | -3 | 0 | N/A |
| 3/31/2019 | 11 | 0 | -3 | 0 | N/A |
| 12/31/2018 | 9 | 0 | -3 | -1 | N/A |
| 9/30/2018 | 9 | 0 | -3 | 0 | N/A |
| 6/30/2018 | 9 | 0 | -2 | 0 | N/A |
| 3/31/2018 | 8 | 0 | -2 | 1 | N/A |
| 12/31/2017 | 8 | 0 | -1 | 1 | N/A |
| 9/30/2017 | 7 | 0 | N/A | N/A | N/A |
| 6/30/2017 | 7 | 0 | N/A | N/A | N/A |
| 3/31/2017 | 6 | 0 | N/A | N/A | N/A |
| 12/31/2016 | 6 | 0 | N/A | -1 | N/A |
| 12/31/2015 | 3 | 1 | N/A | 0 | N/A |
| 12/31/2014 | 2 | 0 | N/A | N/A | N/A |
| 12/31/2013 | 3 | 0 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ATRY is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.5%).
Earnings vs Market: ATRY is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: ATRY is expected to become profitable in the next 3 years.
Revenue vs Market: ATRY's revenue (6.7% per year) is forecast to grow faster than the Spanish market (4.4% per year).
High Growth Revenue: ATRY's revenue (6.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ATRY's Return on Equity is forecast to be low in 3 years time (4.4%).